Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation.

MLA

Gahr, Maximilian, et al. “Incidence of Inpatient Cases with Mental Disorders Due to Use of Cannabinoids in Germany: A Nationwide Evaluation.” European Journal of Public Health, vol. 32, no. 2, Apr. 2022, pp. 239–45. EBSCOhost, https://doi.org/10.1093/eurpub/ckab207.

APA

Gahr, M., Ziller, J., Keller, F., Muche, R., Preuss, U. W., & Schönfeldt-Lecuona, C. (2022). Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation. European Journal of Public Health, 32(2), 239–245. https://doi.org/10.1093/eurpub/ckab207

Chicago

Gahr, Maximilian, Julia Ziller, Ferdinand Keller, Rainer Muche, Ulrich W Preuss, and Carlos Schönfeldt-Lecuona. 2022. “Incidence of Inpatient Cases with Mental Disorders Due to Use of Cannabinoids in Germany: A Nationwide Evaluation.” European Journal of Public Health 32 (2): 239–45. doi:10.1093/eurpub/ckab207.